James Coutcher, Sr.Director and Global Head of Emerging Methods and Solutions for IQVIA
In today’s complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are…
Continue Reading
Artificial intelligence (AI)-based diagnostic systems have been reported to improve fundus disease screening in previous studies. This multicenter prospective self-controlled clinical trial aims to evaluate the diagnostic performance of a deep learning system (DLS)…
Continue Reading
Jim DiCesare, Sr. Director, Study Operations, IQVIA Clinical Trial Payments
Escalating competition for clinical trial sites, in tandem with other industry-wide challenges such as changing regulations; a lack of bandwidth and resources; identifying ideal sites…
Continue Reading
QuantHealth co-founders Arnon Horev and Orr (Ruti Benziman)
What You Should Know:
– In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic…
Continue Reading
Background: The World Health Organization has called for addressing the growing burden of noncommunicable diseases (NCDs) by promoting healthy lifestyles among the population. Regarding patient health, primary care professionals (PCPs) are the first line…
Continue Reading
Gary Shorter – Head, AI and Data Science, IQVIA Technologies
In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.
The clinical trial space is one area where…
Continue Reading
Clinical trial company Lindus Health and US-based Thirty Madison have completed enrolment for a trial to assess the effectiveness of Facet, Thirty Madison’s personalised dermatology telemedicine platform.A novel telehealth platform, Facet offers treatments to…
Continue Reading
During the global pandemic, the world saw firsthand how essential clinical trials were in developing medicines to improve health and extend human life. Clinical research sites, including academic medical centers (AMC), non-AMCs and professional…
Continue Reading
Philochem and Blue Earth Diagnostics celebrate a pivotal advancement in their collaboration, initiating a Phase 1 Clinical Trial with 68Ga-OncoFAP for imaging solid tumors. This partnership aims to explore OncoFAP, a specialized ligand targeting…
Continue Reading
What You Should Know:
– QuantHealth, an AI-powered clinical trial design startup, today announced a major product upgrade to its platform with the launch of Katina, a new tool that utilizes AI to simulate clinical…
Continue Reading
